Dr Avi Spira: Janssen ' s use of new technology to intercept lung cancer

Pr écis: Dr Avi Spira, Global Head of Johnson& Johnson's Lung Cancer Initiative on their use of ML, Robotics and Molecular Technology to intercept lung cancer.YouTube URL: https://www.youtube.com/watch?v=oe5T5RF1Z3EVideo Thumbnail Image: Channels: Access and EvidenceMedicalTags: Janssen

Source: EyeForPharma - July 24, 2019 Category: Pharmaceuticals Authors: Izzy Gladstone Source Type: news